TRANSFORM-1

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

TRANSFORM-1

Jul 2, 2024, 08:18 | Blog

Naveen Pemmaraju: Navitoclax and Ruxolitinib in Patients With Untreated Myelofibrosis

Naveen Pemmaraju shared a post on LinkedIn: “A huge shout out to all of you…

Jun 17, 2024, 07:05 | Societies

15 Posts You Should Not Miss From EHA 2024!

The European Hematology Association (EHA) Hybrid Congress or EHA2024 will took place in Madrid, Spain…

Jun 16, 2024, 14:10 | Insight

Naveen Pemmaraju: TRANSFORM-1 results randomized Phase 3 clinical trial at EHA24

Naveen Pemmaraju shared on X: "Honored to present at EHA24 today the TRANSFORM-1 results from…

All: 3 Posts: 1 - 100

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023